Biopharmaceutical Quality Control with Mass Spectrometry
Overview
Authors
Affiliations
Mass spectrometry (MS) is a powerful technique for protein identification, quantification and characterization that is widely applied in biochemical studies, and which can provide data on the quantity, structural integrity and post-translational modifications of proteins. It is therefore a versatile and widely used analytic tool for quality control of biopharmaceuticals, especially in quantifying host-cell protein impurities, identifying post-translation modifications and structural characterization of biopharmaceutical proteins. Here, we summarize recent advances in MS-based analyses of these key quality attributes of the biopharmaceutical development and manufacturing processes.
Liu Q, Hong J, Zhang Y, Wang Q, Xia Q, Knierman M Sci Rep. 2024; 14(1):20239.
PMID: 39215123 PMC: 11364755. DOI: 10.1038/s41598-024-70914-5.
Mesonzhnik N, Belushenko A, Novikova P, Kukharenko A, Afonin M Antibodies (Basel). 2024; 13(3).
PMID: 39189237 PMC: 11348383. DOI: 10.3390/antib13030066.
Kristensen D, Orgaard M, Sloth T, Comamala G, Jensen P Anal Chem. 2023; 95(42):15465-15471.
PMID: 37824441 PMC: 10603607. DOI: 10.1021/acs.analchem.3c02609.
Dissecting the structural heterogeneity of proteins by native mass spectrometry.
Reid D, Thibert S, Zhou M Protein Sci. 2023; 32(4):e4612.
PMID: 36851867 PMC: 10031758. DOI: 10.1002/pro.4612.
Qin M, Qian Y, Huang L, Zhong C, Li M, Yu J Front Pharmacol. 2023; 14:1110900.
PMID: 36713836 PMC: 9880169. DOI: 10.3389/fphar.2023.1110900.